Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Clinical trial NCT00910039 · TERMINATED

Trial details

NCT number: NCT00910039
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive/Functional Effects Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2009-04-01
Primary completion: 2012-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.